We welcome the fi nding that Intermittent Preventive Treatment in infants (IPTi) has a signifi cant eff ect on morbidity (Oct 31, p 1533). The drug used, sulfadoxine-pyrimethamine, does not seem to have negative interactions with routine childhood immunisations, its cost is low, and the intervention’s cost-eff ectiveness ratio is highly attractive. An… (More)
Figures and Tables
Sorry, we couldn't extract any figures or tables for this paper.